Thomas M. Greene
Top rated personal injury attorney in Boston, MassachusettsGreene LLP
Attorney Thomas M. Greene is a top-rated, nationally recognized trial attorney in whistleblower litigation and in other types of complex civil litigation, such as personal injury and consumer protection. Since 1992, Greene has represented qui tam whistleblowers in False Claims Act cases across the country in a variety of industries, with successes in defense, public utilities and customs duties cases, and in several segments of the health care industry.
Greene’s national reputation among whistleblower attorneys was established in litigation against the pharmaceutical industry. Greene pioneered the off-label promotion type of False Claims Act litigation in a 1996 case against a large pharmaceutical manufacturer, which he pursued for 8 years without government intervention until it settled in 2004 for $430 million in civil fines and criminal penalties. Since then, the government has recovered more than $14 billion in off-label promotion cases—nearly half of all funds ever recovered under the 150-year-old law.
As managing partner of Greene LLP, Greene oversees a six-attorney operation that has maintained a reputation for leaving no stone unturned. The firm’s low-volume approach means it can devote its resources to the goals of maximizing return in the cases it does take, inside and outside of the courtroom. Among Greene’s litigation successes that each involved investigations of millions of documents: a 2010 civil RICO trial that resulted in a $142 million jury verdict, a 2014 pharmaceutical class action settlement of $325 million, and a 2015 False Claims Act settlement of $231 million with a drug testing laboratory.
Just as few firms can compete with Greene LLP’s experience and skill in investigating and prosecuting fraud, few are better versed on the nuances of the False Claims Act and its retaliation protections, the law of which Greene LLP has helped to shape. In 2016, the United States Supreme Court ruled in the firm’s favor in Universal Health Services v. United States ex rel. Escobar, resolving a split among Circuit Courts of Appeal and unanimously holding for the first time that “implied certification” cases—in which material half-truths about goods and services constitute fraud on the government—are viable types of False Claims Act cases.
For his work, Greene has been featured in the New York Times and Wall Street Journal, on NBC’s “Dateline,” and on National Public Radio. He is a frequent speaker on False Claims Act and other fraud litigation, including before a committee of the United States House of Representatives.
Practice areasPersonal injury - general: plaintiff, Employment & labor: employee, Employment litigation: plaintiff, Class action/mass torts: plaintiff, Personal injury - products: plaintiff
Wrongful death, Whistleblower, Retaliation, Pharmaceutical
- 30% Personal injury - general: plaintiff
- 30% Employment & labor: employee
- 20% Employment litigation: plaintiff
- 10% Class action/mass torts: plaintiff
- 10% Personal injury - products: plaintiff
First Admitted: 1977, Massachusetts
Professional Webpage: https://www.falseclaimsattorneys.com/thomas-m-greene.html
- Boston College, cum laude, 1974
- Plaintiffs’ Steering Committee in the MDL arising from off-label promotion of Neurontin, In re Neurontin Marketing and Sales Practices, Chairman
- Plaintiffs’ Steering Committee, In re Air Crash Disaster, an MDL arising from the crash of American Eagle Flight 3379 on approach to the Raleigh-Durham International Airport
- “A New Weapon in Pharma Cases”, Trial magazine
- On invitation, testified about litigation tools to combat waste, fraud and abuse in health care, including the False Claims Act and tools available to other health care payors., Witness, Fostering Innovation to Fight Waste, Fraud, and Abuse in Health Care, U.S. House of Representatives, Committee on Energy and Commerce, Subcommittee on Health, 2013
- Speaker, Pharmaceutical Litigation, Harvard Law School
- Speaker, Pharmaceutical Litigation, Johns Hopkins University
- Speaker, Pharmaceutical Litigation, Boston College
- Speaker, Pharmaceutical Litigation, Northwestern Law School
- Our Daily Meds by former New York Times reporter Melody Petersen
- Nominated for 2011 Public Justice Trial Lawyer of the Year Award and selected Finalist, for work on 2010 federal RICO trial and verdict Kaiser Foundation Health Plan v. Pfizer, the first time RICO was used against a pharmaceutical company and first time a private party sued a pharmaceutical company for fraudulent off-label promotion of drugs., Finalist, Trial Lawyer of the Year Award, Public Justice Foundation, 2011
- Invited to participate in "Battle of the Lawyers," in which four attorneys recreated closing arguments from prominent Massachusetts cases. Awarded "Most Compelling Argument" for recreation of closing argument from Kaiser Foundation Health Plan v. Pfizer by jury of journalists, judges and attorneys., Most Compelling Argument, 2010 Massachusetts Lawyers Weekly Battle of the Lawyers, 2010
- $20M Lincare False Claims Act settlement, 2017
- $6.5M Carolinas Healthcare System False Claims Act settlement, 2017
- $2.8M Bartlett Holdings, Inc. False Claims Act settlement, 2016
- $227M Millennium Health, LLC False Claims Act settlement, 2015
- $325M RICO settlement with Pfizer, Inc., acting as lead counsel and Chairman of Plaintiffs Steering Committee, 2014
- False Claims Act
- Government Programs & Fraud
- Health Care
Office location for Thomas M. Greene
One Liberty Square
Boston, MA 02109
- Super Lawyers: 2011 - 2016, 2020 - 2022